Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eric Ostertag currently holds 827,320 shares of Poseida Therapeutics, Inc. (PSTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Ostertag has been a net seller of PSTX stock. They have purchased $500.0K and sold $8.0M worth of shares.
Eric Ostertag's most recent insider trade was on Feb 1, 2023, when they sold 11,776 shares at $7.00 per share.
Eric Ostertag serves as Executive at Poseida Therapeutics, Inc. (PSTX). They have executed 58 insider transactions totaling $8.5M over their tenure at the company.
Eric Ostertag holds the position of Executive at Poseida Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Eric Ostertag has shown a selling trading pattern, with $500.0K in total purchases and $8.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Eric Ostertag was on Aug 6, 2021, when they sold $1.0M worth of PSTX shares. This transaction involved 111,149 shares at $9.15 per share.
Eric Ostertag currently owns 827,320 shares of Poseida Therapeutics, Inc. (PSTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eric Ostertag's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eric Ostertag has 58 Form 4 filings on record as an insider at Poseida Therapeutics, Inc..
Set alerts for Eric Ostertag and 40,000+ other insiders.